Table 3.
Vaccine Effectiveness 95% vs. 80% |
Mild Common AEFI 1 Day of Headache, Fatigue vs. 1–2 Days of Fever |
Rare but Severe AEFI No Risk vs. Same Risk as Flu Vaccine |
No. Doses 1 Dose vs. 2 Doses |
|
---|---|---|---|---|
Total (n = 13,451) | ||||
% Pos * | 79.2 | 90.1 | 85.3 | 61.5 |
Estimate (SD) | 1.138 | 1.993 | 1.731 | 0.788 |
SD | 1.001 | 1.020 | 1.021 | 1.022 |
p value | <0.001 | <0.001 | <0.001 | <0.001 |
Vaccine hesitancy score ≤18 (n = 4055) | ||||
% Pos * | 77.2 | 87.5 | 79.7 | 66.9 |
Estimate | 1.137 | 1.889 | 1.675 | 0.827 |
SD | 1.002 | 1.030 | 1.040 | 1.041 |
p value | <0.001 | <0.001 | <0.001 | <0.001 |
Vaccine hesitancy score 19–24 (n = 6591) | ||||
% Pos * | 81.5 | 92.4 | 83.8 | 59.7 |
Estimate | 1.140 | 2.070 | 1.724 | 0.759 |
SD | 1.002 | 1.038 | 1.031 | 1.032 |
p value | <0.001 | <0.001 | <0.001 | <0.001 |
Vaccine hesitancy score ≥25 (n = 2805) | ||||
% Pos * | 76.7 | 94.3 | 89.3 | 63.1 |
Estimate | 1.135 | 2.136 | 1.835 | 0.798 |
SD | 1.003 | 1.046 | 1.048 | 1.049 |
p value | <0.001 | <0.001 | <0.001 | <0.001 |
* % Pos was the proportion of respondents who had a positive preference for a vaccine attribute.